Susan Matesanz, MD (Credit: Children’s Hospital of Philadelphia) An outpatient subspecialty care utilization study recently published in Neurology showed a low rate of annual neurology follow-up...
WATCH TIME: 3 minutes “If we did not have the ability to identify the alpha-synuclein, there may be such soft motor signs that, in essence, you...
WATCH TIME: 7 minutes “As an MS expert, everyone has their own system of how they do things and their own patterns and methods, but it...
WATCH TIME: 10 minutes “We learned from many years of research that the risk of Alzheimer disease (AD) starts to manifest in women’s brains already in...
David K.B. Li, MD, FRCPC (Credit: NARCRMS) In December 2023, The Consortium of Multiple Sclerosis Centers (CMSC) launched a continuing medical education (CME) activity focusing on...
WATCH TIME: 7 minutes “Dementia is many problems at the same time, and developing drugs that modify the disease requires addressing multiple issues simultaneously.” Emerging therapies...
WATCH TIME: 7 minutes “Tyrosine kinase inhibitors act like a ‘double-edged sword’, lowering inflammation while promoting autophagy, effectively clearing toxic proteins from the brain.” New therapies...
WATCH TIME: 4 minutes “It’s a really important pearl to remember: dedicate your time, give them your active listening, and that’s how you’re going to build...
WATCH TIME: 5 minutes “I think one of the biggest things I’ve learned in this study is that 100% of everyone has the patient’s care and...
WATCH TIME: 4 minutes Welcome to this special edition of Neurology News Network. I’m Marco Meglio. According to a recent announcement, REGENXBIO has initiated enrollment in...
WATCH TIME: 5 minutes “We have a really great calling to educate other people about neurology, about neurologic conditions. And whether that’s the public or non-neurologists...
Stuart Isaacson, MD, FAAN Responder rate data from the open-label, phase 3 InfusON trial (NCT02339064) presented at the 3rd Annual Advanced Therapeutics in Movement and Related...